We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELOX
3326
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$78K ﹤0.01%
740
+566
+325% +$67.8K
CMPI
3327
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$78K ﹤0.01%
+6,812
New +$87.3K
BTAI icon
3328
BioXcel Therapeutics
BTAI
$35.8M
$77K ﹤0.01%
111
-262
-70% -$197K
CDL icon
3329
VictoryShares US Large Cap High Div Volatility Wtd ETF
CDL
$410M
$77K ﹤0.01%
1,908
– –
CYTK icon
3330
Cytokinetics
CYTK
$10.1B
$77K ﹤0.01%
3,547
-4,105
-54% -$96K
EPM icon
3331
Evolution Petroleum
EPM
$133M
$77K ﹤0.01%
34,268
+25,378
+285% +$67.5K
MSB
3332
Mesabi Trust
MSB
$308M
$77K ﹤0.01%
3,602
+3,130
+663% +$59K
TGTX icon
3333
TG Therapeutics
TGTX
$7.41B
$77K ﹤0.01%
2,869
-15,833
-85% -$364K
GRTX
3334
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$77K ﹤0.01%
8,478
+7,063
+499% +$55.9K
COUP
3335
DELISTED
Coupa Software Incorporated
COUP
$77K ﹤0.01%
282
-2,274
-89% -$663K
NBL
3336
DELISTED
Noble Energy, Inc.
NBL
$77K ﹤0.01%
8,960
-23,713
-73% -$232K
GFN
3337
DELISTED
General Finance Corporation
GFN
$77K ﹤0.01%
12,191
+9,706
+391% +$61.7K
AZPN
3338
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$77K ﹤0.01%
610
+582
+2,079% +$73.5K
DBVT
3339
DBV Technologies
DBVT
$869M
$76K ﹤0.01%
4,412
+4,023
+1,034% +$116K
EPI icon
3340
WisdomTree India Earnings Fund ETF
EPI
$2.03B
$76K ﹤0.01%
3,200
+1,100
+52% +$25K
ET icon
3341
Energy Transfer Partners
ET
$72.1B
$76K ﹤0.01%
14,144
+8,228
+139% +$52.2K
FUNC icon
3342
First United
FUNC
$296M
$76K ﹤0.01%
6,460
-4,366
-40% -$49.7K
ONT
3343
Onterris Inc
ONT
$623M
$76K ﹤0.01%
+3,197
New +$81.2K
MYFW icon
3344
First Western Financial
MYFW
$313M
$76K ﹤0.01%
5,905
-704
-11% -$9.64K
PDLB icon
3345
Ponce Financial Group
PDLB
$507M
$76K ﹤0.01%
11,990
+9,472
+376% +$61.7K
PVBC
3346
DELISTED
Provident Bancorp
PVBC
$76K ﹤0.01%
9,728
+7,430
+323% +$58.7K
SDC
3347
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$76K ﹤0.01%
+6,505
New +$59.8K
RTLR
3348
DELISTED
Rattler Midstream LP Common Units
RTLR
$76K ﹤0.01%
12,772
+10,444
+449% +$82K
ANNX icon
3349
Annexon
ANNX
$860M
$75K ﹤0.01%
+2,476
New +$58.1K
AVTX icon
3350
Avalo Therapeutics
AVTX
$1.01B
$75K ﹤0.01%
11
+9
+450% +$67.6K
132 133
134
135 136

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.